Pen-sharing poses a risk for transmission of blood-borne pathogens Adverse Reactions Most common adverse reactions (incidence 5%) are: nausea, diarrhea, vomiting, constipation, abdominal pain, dysesthesia, headache, fatigue, dyspepsia, dizziness, abdominal distention, eructation, hypoglycemia in patients with T2D, flatulence, gastroenteritis, gastroesophageal reflux disease, and hair loss Drug Interactions When initiating Wegovy , consider reducing the dose of concomitantly administered insulin secretagogues or insulin to reduce the risk of hypoglycemia
the avoidance pattern in the community is precautionary, based on the molecule's copper content
It is not FDA-approved, which means it cannot be legally sold for human consumption
Focus on foods rich in vitamins and minerals to prevent nutrient deficiencies and consider taking supplements (iron B vitamins) if necessary to support your nutrition while on semaglutide
Tips for clinicians and care teams Ask about activity habits when prescribing GLP-1s